Akinobu Hamada

5.0k citations

178 papers · 3.7k indexed · h-index 36

Impact in

Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in

Oncology 100
- Lung Cancer Research Studies 23
- Drug Transport and Resistance Mechanisms 22
- Colorectal Cancer Treatments and Studies 14
- Cancer Immunotherapy and Biomarkers 13
- HER2/EGFR in Cancer Research 12
Virology 9

Co-authors: Hideyuki Saito Hiroshi Watanabe Masahiro Nakano Takashi Shimada Noriko Iwamoto Kenji Tamura Takanobu Matsuzaki Takeo Kawaguchi
Journals: Biological and Pharmaceutical Bulletin (14 papers)Journal of Clinical Oncology (10 papers)Annals of Oncology (8 papers)Drug Metabolism and Pharmacokinetics (7 papers)Cancer Chemotherapy and Pharmacology (7 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Akinobu Hamada

172 papers receiving 3.7k citations

Peers

Countries citing papers authored by Akinobu Hamada

Since Specialization

Citations

This map shows the geographic impact of Akinobu Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinobu Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinobu Hamada more than expected).

Fields of papers citing papers by Akinobu Hamada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akinobu Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinobu Hamada. The network helps show where Akinobu Hamada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Akinobu Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Akinobu Hamada Line = papers co-authored together Akinobu Hamada links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling Neoplasia ·Sho Sato, Shigehiro Yagishita, Hiroshi Yoshida, Daisuke Shintani, A. Jezierski, Tadaaki Nishikawa, Masanori Yasuda, Keiji Furuuchi, Toshimitsu Uenaka, Akinobu Hamada, Kosei Hasegawa	2025	0
2	WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer Cancer Letters ·Gaku Yamamoto, Kosuke Tanaka, Ryo Kamata, Jimmy Alejandro, 장안서, 최길광, Christin Lehmann, J. Lacik, Shigehiro Yagishita, Akinobu Hamada, Yuki Shinno, Tatsuya Yoshida, Hidehito Horinouchi, Yuichiro Ohe, Shun‐ichi Watanabe, Yasushi Yatabe, Hidenori Kitai, Satoshi Konno, Susumu Kobayashi, Akihiro Ohashi	2024	4
3	Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510) Cancer ·Tadaaki Nishikawa, Shigeki Kakunaga, Kenji Tamura, Masashi Ando, Toshifumi Ozaki, Akira Kawai, Takafumi Ueda, Bettina C. Human, YaTao GUO, 進典宇佐美, Daphne Glazer, Akinobu Hamada, Akihiko Yoshida, Akihiro Hirakawa, Taro Shibata, Kenichi Nakamura, Kan Yonemori	2024	2
4	Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping Diagnostics ·Yuki Kojima, Emi Noguchi, Т.В. Олешко, Shigehiro Yagishita, Shu Yazaki, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Tatsunori Shimoi, E. A. Maxwell, Hiroshi Terasaki, Paola Uasapud, Yasuhiro Fujiwara, Akinobu Hamada, Kenji Tamura, Kan Yonemori	2023	1
5	Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLC JTO Clinical and Research Reports ·D. A. Lisaev, Tatsuya Yoshida, Shigehiro Yagishita, احمد سيد طه سيد, Yuji Matsumoto, Yuki Shinno, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Kazuhisa Takahashi, Noriko Motoi, Akinobu Hamada, Yuichiro Ohe	2023	3
6	Steady-state pharmacokinetics of plasma tenofovir alafenamide (TAF), tenofovir (TFV) and emtricitabine (FTC), and intracellular TFV-diphosphate and FTC-triphosphate in HIV-1 infected old Japanese patients treated with bictegravir/FTC/TAF Global Health & Medicine ·Trung Hieu Tran, K. Tsuchiya, Akira Kawashima, Kôji Watanabe, Yoshiharu Hayashi, 篤俊池田, Akinobu Hamada, Hiroyuki Gatanaga, Shinichi Oka	2023	4
7	Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancer Lung Cancer ·Štimac Davor, Shigehiro Yagishita, احمد سيد طه سيد, Yoshiharu Hayashi, Yuki Takeyasu, Ken Masuda, Yuki Shinno, Yusuke Okuma, Tatsuya Yoshida, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Hiroshi Mukae, Yuichiro Ohe, Akinobu Hamada	2023	1
8	Anticancer Effects of Fucoxanthin in a PDX Model of Advanced Stage Pancreatic Cancer with Alteration of Several Multifunctional Molecules SHILAP Revista de lepidopterología ·Masaru Terasaki, 徐红芳, Takuji Tanaka, H. Maeda, Masaki Shibata, Kazuo Miyashita, Yasuhiro Kuramitsu, Junichi Hamada, Tohru Ohta, Shigehiro Yagishita, Akinobu Hamada, Yasunari Sakamoto, Susumu Hijioka, Chigusa Morizane, Mami Takahashi	2023	1
9	Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia npj Precision Oncology ·Fahmi Purba Khairul, Toshihide Ueno, Masanaka Sugiyama, Shinya Kojima, William Boehart, Kayoko Tao, Hyeongmin Moon, Kouya Shiraishi, Shigehiro Yagishita, Shinji Kohsaka, Mamoru Kato, Nobutaka Kiyokawa, Yasushi Goto, Yasushi Yatabe, Akinobu Hamada, Hiroyuki Mano, Chitose Ogawa, Yosuke Tanaka	2023	1
10	A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics The Analyst ·Noriko Iwamoto, Yoshinobu Koguchi, 马天璇, Akinobu Hamada, Atsushi Yonezawa, Brian Piening, Eric Tran, Bernard A. Fox, William L. Redmond, Takashi Shimada	2022	4
11	Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis Clinical Cancer Research ·Mikiko Suzuki, Shigehiro Yagishita, Kiyoshi Sugihara, Yusuke Ogitani, Tadaaki Nishikawa, احمد سيد طه سيد, Tatiane dos Santos, Takahiro Jikoh, Yasushi Yatabe, Kan Yonemori, Kenji Tamura, Kosei Hasegawa, Akinobu Hamada	2021	24
12	Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations Molecular Cancer Therapeutics ·D. A. Lisaev, Shigehiro Yagishita, Yoshiharu Hayashi, 篤俊池田, Mikiko Suzuki, Shinji Kohsaka, Toshihide Ueno, Yuji Matsumoto, Hidehito Horinouchi, Yuichiro Ohe, Shun‐ichi Watanabe, Noriko Motoi, Yasushi Yatabe, Hiroyuki Mano, Kazuhisa Takahashi, Akinobu Hamada	2021	6
13	Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library Cancer Science ·Shigehiro Yagishita, Ken Kato, Mami Takahashi, Toshio Imai, Yasushi Yatabe, Takeshi Kuwata, Mikiko Suzuki, Atsushi Ochiai, Atsushi Ohtsu, Kazuaki Shimada, Toshirou Nishida, Akinobu Hamada, Hiroyuki Mano	2021	13
14	Report of the use of patient‐derived xenograft models in the development of anticancer drugs in Japan Cancer Science ·Ryo Tsumura, Yoshikatsu Koga, Akinobu Hamada, Takeshi Kuwata, Hiroki Sasaki, Toshihiko Doi, Katsuji Aikawa, Akihiro Ohashi, Ikumi Katano, Yoshinori Ikarashi, Mamoru Ito, Atsushi Ochiai	2020	11
15	Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS Clinical Cancer Research ·Yoshihiro Yoshitake, Daiki Fukuma, Akira Yuno, Masatoshi Hirayama, Hideki Nakayama, Takuya Tanaka, Masashi Nagata, Mariana Silva Revoredo Alves, Kenta Kawahara, Yoshihiro Nakagawa, Ryoji Yoshida, Akiyuki Hirosue, Hidenao Ogi, Akimitsu Hiraki, Hirofumi Jono, Akinobu Hamada, Koji Yoshida, Yasuharu Nishimura, Yusuke Nakamura, Masanori Shinohara	2014	123
16	Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor Clinical Cancer Research ·Yusuke Tomita, Akira Yuno, Hirotake Tsukamoto, Satoru Senju, Yasuhiro Kuroda, Masatoshi Hirayama, Atsushi Irie, Kenta Kawahara, Junji Yatsuda, Akinobu Hamada, Hirofumi Jono, Koji Yoshida, Takuya Tsunoda, Hirotsugu Kohrogi, Yoshihiro Yoshitake, Yusuke Nakamura, Masanori Shinohara, Yasuharu Nishimura	2013	50
17	Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient Journal of Cancer Research and Therapeutics ·Yukari Tsubata, Akinobu Hamada, Akihisa Sutani, Takeshi Isobe	2012	18
18	Determination of aflatoxins in cacao products by immunoaffinity column-HPLC methods. Osamu Kawamura, Akinobu Hamada	2009	2
19	Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer Clinical Cancer Research ·Akinobu Hamada, Tristan M. Sissung, Douglas K. Price, Romano Danesi, Cindy H. Chau, Nima Sharifi, David Venzon, Kenji Maeda, Keisuke Nagao, Alex Sparreboom, Hiroaki Mitsuya, William L. Dahut, William D. Figg	2008	153
20	Basic Study on Gastro-Intestinal Toxicity Caused by Macrolide Antibiotics. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Jin Tokunaga, Keiko Okamura, Akinobu Hamada, Nobuaki Shiraki, Shinji Miyamoto, Junko Fujii, Kazuhiko Arimori, Masahiro Nakano	2001	1

About Akinobu Hamada

Akinobu Hamada is a scholar working on Oncology, Virology, Pulmonary and Respiratory Medicine, Genetics and Pharmacology, having authored 178 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (23 papers), Drug Transport and Resistance Mechanisms (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Cancer therapeutics and mechanisms (17 papers), Colorectal Cancer Treatments and Studies (14 papers), Cancer Immunotherapy and Biomarkers (13 papers) and HER2/EGFR in Cancer Research (12 papers). The work is most often cited by research in Oncology (1.6k citations), Genetics (341 citations), Hematology (351 citations), Pharmacology (216 citations) and Virology (99 citations). Akinobu Hamada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hideyuki Saito, Hiroshi Watanabe, Masahiro Nakano, Takashi Shimada, Noriko Iwamoto, Kenji Tamura, Takanobu Matsuzaki, Takeo Kawaguchi, Yasuhiro Fujiwara and Kan Yonemori. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Journal of Clinical Oncology, Annals of Oncology, Drug Metabolism and Pharmacokinetics and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact